Transgene SA (EPA:TNG)
France · Delayed Price · Currency is EUR 0.9720
+0.0480 (5.19%)
At close: Dec 22, 2025
Transgene Market Cap
Transgene has a market cap or net worth of €253.02 million as of December 22, 2025. Its market cap has increased by 168.10% in one year.
Market Cap
253.02M
Enterprise Value
267.31M
Revenue
7.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.97
Market Cap Chart
Since March 30, 1998, Transgene's market cap has increased from 151.86M to 253.02M, an increase of 66.61%. That is a compound annual growth rate of 1.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 253.02M | 181.90% |
| Dec 31, 2024 | 89.75M | -34.86% |
| Dec 29, 2023 | 137.78M | -16.38% |
| Dec 30, 2022 | 164.76M | -33.52% |
| Dec 31, 2021 | 247.84M | 79.73% |
| Dec 31, 2020 | 137.90M | 6.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 126.72B |
| Sanofi | 100.24B |
| Sartorius Stedim Biotech | 19.88B |
| bioMérieux | 12.86B |
| Eurofins Scientific SE | 10.93B |
| Ipsen | 9.88B |
| ABIVAX Société Anonyme | 7.78B |
| Virbac | 2.93B |